MED-EL India, the Indian subsidiary of the global leading provider of hearing implant systems MED-EL, known for developing innovative products to help patients overcome hearing loss worldwide, announced the “Roadmap and Opportunities for the growth of hearing aid technology and impairment treatments in India in the next decade’ basis an industry conclave held in NCR.

The conclave was attended by MED-EL global chief executive officer Dr. Ingeborg Hochmair and other healthcare professionals, surgeons and industry experts to address the needs of the hearing impaired in India.

Tejinder Singh, director at MED-EL India said, “In India, it is estimated that up to 8.8% of the population suffers from hearing loss with approximately 3.8 million children waiting for cochlear implants. If children are implanted early with a cochlear implant, they can go on to lead a normal life and develop through the education system. Our company vision is to overcome hearing loss as a barrier to communication and quality of life. It is our endeavour at MED-EL to provide a service that is reliable, trustworthy, and offers the very latest in technology to the many millions of Indians who can benefit from a cochlear implant.”

Prof. (Dr.) J.M. Hans, Padmashree awardee and renowned surgeon said “There are more solutions available than ever before to restore the gift of hearing to the Indian people who suffer from various types of hearing loss. Early implantation of children with hearing loss allows them to develop listening and speaking skills and increase their opportunities for the future.”  

The number of cochlear implantations in India is growing rapidly, with investments from the Government and the increased demand from the Indian population. MED-EL has been a principal supplier for cochlear implants and is supporting government sponsored cochlear implant programs in several states like Tamil Nadu, Kerala, Delhi, Chhattisgarh, Assam, Gujarat and Madhya Pradesh; to name a few. Through the Indian subsidiary, company continues to expand and support 100+ clinics in 45+ major cities in India, Sri Lanka, Nepal and Bangladesh. MED-EL is helping to drive this industry with long-term implant solutions and support that can bring major economic benefits to the country.  MED-EL India is positioned not only as a supplier but as a long-term service provider for the entirety of the implant cycle.

Tejinder Singh, Director, MED-EL India added, “At MED-EL India, we have a young, enthusiastic and professionally competent team. By working closely together with our healthcare partners and Government we can really make life changing differences for the millions of Indian affected with hearing loss and to the Indian economy in the next 10 years.”

MED-EL has been represented in India since the past 25 years (1992) but has a direct presence through a 100% owned subsidiary operation established in India since 2006 (10 years) and provides the widest range of hearing solutions to treat numerous degrees of hearing loss such as conductive, sensorineural, mixed and neural hearing loss. The company’s solutions are distinguished by performance, ease of use and reliability.

Austria-based MED-EL Medical Electronics is a leading provider of hearing implant systems with 29 subsidiaries worldwide. The family-owned business is one of the pioneers in the industry. The two Austrian scientists Ingeborg and Erwin Hochmair developed the world’s first microelectronic-multichannel Cochlear-Implant in 1977. The cochlear implant was and remains the first replacement of a human sense, the sense of hearing. In 1990 they laid the foundation for the successful growth of the company when they hired their first employees. To date, the company has grown to more than 1700 employees around the world.

Today MED-EL offers the widest range of implantable solutions worldwide to treat various degrees of hearing loss: cochlear and middle ear implant systems, EAS combined Electric Acoustic Stimulation (EAS) hearing implant system and auditory brainstem implants as well as the world´s first active bone conduction implant.